Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 616 AL 630

NeuroEPO plus (NeuralCIM(®)) in Alzheimer's disease: Post-trial observational follow-up study

Sosa Pérez S, Urrutia Amable N, Viada González CE, Lorenzo-Luaces P, Sánchez Valdés L, Crombet Ramos T, León Monzón K, Rodríguez Obaya TJ, Pérez Ruiz L.

J Alzheimers Dis. 2025 Dec;108(3):1422-1435. doi: 10.1177/13872877251386885. Epub 2025 Oct 22.

Memory for Music (M4M) protocol for an international randomised controlled trial: effects of individual intensive musical training based on singing in non-musicians with Alzheimer's disease

Lichtensztejn M, Cui AX, Geretsegger M, Lundervold AJ, Koelsch S, Pfabigan DM, Assmus J, Langeland E, Ruiz M, Tabernig C, Skogseth RE, Gold C.

BMJ Open. 2025 Oct 20;15(10):e095136. doi: 10.1136/bmjopen-2024-095136.

The impact of music-based intervention on cognitive function and brain functional magnetic resonance imaging in people with mild Alzheimer's disease

Lyu J, Zhang W, De J, Shan B, Mao G, Jiang W, Rong X, Li W, Li M, Hu Y, Jia D, Gao W, Yang D.

J Alzheimers Dis. 2025 Nov;108(2):779-789. doi: 10.1177/13872877251379419. Epub 2025 Oct 3.

The effect of animal assisted rehabilitation practices on symptoms of Alzheimer's patients: systematic review and meta-analysis

Tüzün Özdemir S, Özer S.

Geriatr Nurs. 2025 May-Jun;63:521-527. doi: 10.1016/j.gerinurse.2025.03.045. Epub 2025 Apr 24.

Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer 's disease: A systematic review and network meta- analysis

Cao W, Zhu B, Liu Z, Jia X, Zhao H, Gu N, Chang H, Xi J, Li R, Guo K, Shen J, Ding L, Sun F, Di Z.

Neuroscience. 2025 Jan 26;565:29-39. doi: 10.1016/j.neuroscience.2024.11.029. Epub 2024 Nov 15.

A multi-modal medical management and lifestyle intervention increase cerebral blood flow and lowers diabetic risk in persons with early Alzheimer's disease: Mid-trial results from the PREVENTION trial

Bramen JE, Siddarth P, Popa ES, Kress GT, Rapozo MK, Hodes JF, Ganapathi AS, Sparks WM, Tongson YM, Torres AM, Meysami S, Slyapich CB, Glatt RM, Pierce K, Miller KJ, Elhelou SH, Porter VR, Wong C, Kim M, Panos S, Hirsch DA, Raji CA, Bookheimer SY, Hood L, Roach JC, Merrill DA.

J Alzheimers Dis. 2025 Dec;108(4):1819-1833. doi: 10.1177/13872877251388933. Epub 2025 Nov 16.

Therapeutic Efficacy of Autologous Blood-Derived Stem Cells with Growth Factors in Moderate to Severe Alzheimer's Disease: A Clinical Trial

Lee WJ, Cho K, Lee D, Lee S, Kim GW.

Mol Neurobiol. 2025 Dec 10;63(1):277. doi: 10.1007/s12035-025-05583-0.

Associations between selected genetic variants and lipid profile variability in response to statins in Alzheimer's disease: a prospective observational study

Oliveira FF, Almeida SS, Chen ES, Bertolucci PHF, Smith MC.

Sao Paulo Med J. 2025 Aug 15;143(4):e2024160. doi: 10.1590/1516-3180.2024.0160.27112024. eCollection 2025.

A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease

Fuseya K, Mimura Y, Nakajima S, Mimura M, Kasanuki K, Noda Y.

J Alzheimers Dis. 2025 May;105(1):28-43. doi: 10.1177/13872877251325887. Epub 2025 Mar 20.

Acoustic Stimulation to Improve Slow-Wave Sleep in Alzheimer's Disease: A Multiple Night At-Home Intervention

Van den Bulcke L, Davidoff H, Heremans E, Potts Y, Vansteelandt K, De Vos M, Christiaens D, Emsell L, Jacobson LH, Hoyer D, Buyse B, Vandenbulcke M, Testelmans D, Van Den Bossche M.

Am J Geriatr Psychiatry. 2025 Jan;33(1):73-84. doi: 10.1016/j.jagp.2024.07.002. Epub 2024 Jul 8.

Efficacy of probiotic supplementation in influencing cognitive function in Alzheimer's disease: A systematic review and meta-analysis

Liu W, Guo J, Dong Y, Li J, Wang Y.

J Food Sci. 2025 Jul;90(7):e70037. doi: 10.1111/1750-3841.70037.

Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial

Haaland B, Dickson SP, Santana AF, Tanzi RE, Dubois B, Peters O, Grimmer T, Christensen J, Mallinckrodt C, Schneeberger A, Hendrix SB.

J Alzheimers Dis. 2025 Nov;108(1):234-242. doi: 10.1177/13872877251375985. Epub 2025 Sep 15.

Synthetic control methods for n-of-1 and parallel-group trials in Alzheimer's disease: A proof-of-concept study using the I-CONECT

Wu CY, Chen L, Dickson JR, Zhang B, Arnold SE, Dodge HH.

Alzheimers Dement. 2025 Jul;21(7):e70460. doi: 10.1002/alz.70460.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): results of a randomised controlled trial

Forstmeier S, Maercker A, Bohli L, Savaskan E, Roth T.

Aging Ment Health. 2025 Feb;29(2):359-368. doi: 10.1080/13607863.2024.2393748. Epub 2024 Aug 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias